Valens VP Finance sells 18,827 company shares
Valens Semiconductor VP Finance Yael Rozenberg Haine reported an exercise-and-sell transaction in the company’s ordinary shares.
Rhea-AI Filing Summary
Valens Semiconductor VP Finance Yael Rozenberg Haine reported an exercise-and-sell transaction in the company’s ordinary shares. On June 15, 2026, she sold a total of 18,827 ordinary shares in open-market trades at $2.347 and $2.36 per share, pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. On the same date, she exercised stock options to acquire 1,453 ordinary shares at an exercise price of $0.86 per share, and the underlying shares were then sold that day. Following these transactions, she directly owns 145,275 ordinary shares of Valens Semiconductor Ltd.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Rozenberg Haine Yael
Role
VP Finance
Sold
18,827 shs ($44K)
Approx. gross sale proceeds
$44K
Approx. exercise cost
$1K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 1,453 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 1,453 | $0.86 | $1K |
| Sale | Ordinary Shares | 1,453 | $2.36 | $3K |
| Sale | Ordinary Shares | 17,374 | $2.347 | $41K |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 contracts (Direct);
Ordinary Shares — 145,275 shares (Direct)
Footnotes (5)
- F1. The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2026
- F2. The shares were acquired upon the exercise of stock options
- F3. The shares sold were acquired upon the exercise of stock options on the same date
- F4. The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.
- F5. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
Key Figures
Shares sold: 18,827 shares
Sale prices: $2.347 and $2.36 per share
Options exercised: 1,453 shares
+4 more
7 metrics
Shares sold
18,827 shares
Open-market sales on June 15, 2026
Sale prices
$2.347 and $2.36 per share
Weighted average prices for June 15, 2026 trades
Options exercised
1,453 shares
Stock options converted to ordinary shares on June 15, 2026
Option exercise price
$0.86 per share
Exercise price of Stock Option (Right to Buy)
Post-transaction holdings
145,275 shares
Ordinary shares directly owned after reported transactions
10b5-1 plan adoption date
March 17, 2026
Date the Rule 10b5-1 trading plan was adopted
Option expiration date
January 11, 2031
Expiration date for the exercised stock options
Key Terms
Rule 10b5-1 trading plan, Stock Option (Right to Buy, Ordinary Shares, weighted average price, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (Right to Buy financial
"Stock Option (Right to Buy) with underlying security title Ordinary Shares"
weighted average price financial
"The price reported is a weighted average price. The reporting person undertakes to provide full information"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
derivative exercise/conversion financial
"transaction_action: derivative exercise/conversion for the stock option transaction"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Valens Semiconductor (VLN) report for Yael Rozenberg Haine?
Valens Semiconductor reported that VP Finance Yael Rozenberg Haine sold 18,827 ordinary shares. The trades occurred on June 15, 2026 as open-market sales and were linked to the exercise of employee stock options on the same date.
Were the Valens Semiconductor (VLN) insider sales made under a Rule 10b5-1 plan?
Yes. The filing states the sales were effectuated under a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2026. Such plans pre-schedule trades, which can make the timing less indicative of discretionary insider sentiment.
What stock options did the Valens Semiconductor (VLN) VP Finance exercise?
She exercised stock options covering 1,453 ordinary shares at an exercise price of $0.86 per share. The options were described as Stock Option (Right to Buy), and the underlying shares were sold on the same date as the exercise.
AI-generated analysis. How Rhea-AI works. Not financial advice.
